Development of therapies in polyglutamine diseases using hepatocyte growth factor (HGF)

使用肝细胞生长因子 (HGF) 开发多聚谷氨酰胺疾病疗法

基本信息

  • 批准号:
    18599002
  • 负责人:
  • 金额:
    $ 2.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

Spinal and bulbar muscular atrophy(SBMA) is an inherited motor neuron disease. The molecular basis of SBMA is the expansion of a trinucleotide CAG repeat, which encodes the polyglutamine(polyQ) tract, in the androgen receptor(Alt) gene. We generated transgenic mouse model expressing the full-length human AR containing either 24 or 97 CAG repeats under the control of a cytomegalovirus enhancer and a chicken β-actin promoter(AR-97Q mice). Hepatocyte growth factor(HGF) was initially identified and molecularly cloned as a potent mitogen for mature hepatocytes. Subsequent studies revealed that HGF exerts multiple biological effects, including mitogenic, motogenic, morphogenic, and anti-apoptotic activities in a wide variety of cells, including neurons, by binding to the c-Met receptor tyrosine kinase(c-Met). HGF is one of the most potent in vitro and in vivo survival-promoting factors for neurons. For example, neurotrophic effects of HGF have been demonstrated in cultured hippocampal neurons and in cultured embryonic spinal motoneurons, and its anti-apoptotic activity in motoneurons is comparable to that of glial cell line-derived neurotrophic factor(GDNF). In the present study, the effects of HGF on motor dysfunction were examined using double transgenic mice overexpressing mutated human AR and HGF. We cross-bred AR-97Q mice with mice over-expressing the HGF. The double transgenic mice showed improvement of their motor function, body weight, lifespan. Overexpression of HDF also ameliorated motor function in the castrated male AR-97Q mice. These findings suggest that HGF over-expression ameliorates SBMA phenotypes in mice.
脊髓延髓肌萎缩症是一种遗传性运动神经元疾病。SBMA的分子基础是雄激素受体(Alt)基因中编码多聚谷氨酰胺(polyQ)序列的三核苷酸CAG重复序列的扩增。我们产生了表达全长人AR的转基因小鼠模型,该全长人AR含有在巨细胞病毒增强子和鸡β-肌动蛋白启动子控制下的24或97个CAG重复序列(AR-97 Q小鼠)。肝细胞生长因子(HGF)最初被鉴定为成熟肝细胞的有效有丝分裂原并进行分子克隆。随后的研究表明,HGF通过与c-Met受体酪氨酸激酶(c-Met)结合,在多种细胞(包括神经元)中发挥多种生物学作用,包括促有丝分裂、促运动、形态发生和抗凋亡活性。肝细胞生长因子(HGF)是体内外最有效的神经元存活促进因子之一。例如,在培养的海马神经元和培养的胚胎脊髓运动神经元中已经证明了HGF的神经营养作用,并且其在运动神经元中的抗凋亡活性与胶质细胞系衍生的神经营养因子(GDNF)相当。在本研究中,使用过表达突变的人AR和HGF的双转基因小鼠研究HGF对运动功能障碍的影响。我们将AR-97 Q小鼠与过表达HGF的小鼠杂交。双转基因小鼠的运动功能、体重、寿命均有所改善。HDF的过表达也改善了去势雄性AR-97 Q小鼠的运动功能。这些发现表明,HGF过表达改善小鼠SBMA表型。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration
  • DOI:
    10.1523/jneurosci.3032-06.2006
  • 发表时间:
    2006-11-22
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Katsuno, Masahisa;Adachi, Hiroaki;Sobue, Gen
  • 通讯作者:
    Sobue, Gen
Gene Expressions Specifically Detected in Motor Neurons(Dynactin 1, Early Growth Response 3, Acety1-CoA Transporter, Death Receptor 5, and Cyclin C)Differentially Correlate to Pathologic Markers in Sporadic Amyotrophic Lateral Sclerosis.
运动神经元中特异检测到的基因表达(动力蛋白 1、早期生长反应 3、乙酰 1-CoA 转运蛋白、死亡受体 5 和细胞周期蛋白 C)与散发性肌萎缩侧索硬化症的病理标志物存在差异相关。
球脊髄性筋萎縮症モデルにおけるシャペロン依存性ユビキチンリガーゼ高発現の効果
伴侣依赖性泛素连接酶高表达对脊髓延髓肌萎缩模型的影响
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    足立弘明;ら
  • 通讯作者:
CHIP overexpression reduces the mutant AR protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model
CHIP 过表达减少突变 AR 蛋白并改善脊髓和延髓肌萎缩转基因小鼠模型的表型
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Adachi;H;Waza;M;Tokui;K;Katsuno;M;Minamiyama;M;Tanaka;F;Doyu;M;Sobue;G
  • 通讯作者:
    G
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ADACHI Hiroaki其他文献

ADACHI Hiroaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ADACHI Hiroaki', 18)}}的其他基金

A Study of the Plan for a Broad-based Economic Bloc in pre-1945 Japan
1945年前日本基础广泛的经济集团计划研究
  • 批准号:
    25370759
  • 财政年份:
    2013
  • 资助金额:
    $ 2.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel therapeutic approaches using the delivery of specific miRNAs for polyglutamine diseases
使用特定 miRNA 递送治疗多聚谷氨酰胺疾病的新治疗方法
  • 批准号:
    23390231
  • 财政年份:
    2011
  • 资助金额:
    $ 2.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A study of the plan for a broad-based bloc in wartime Japan
日本战时基础广泛集团计划研究
  • 批准号:
    21520662
  • 财政年份:
    2009
  • 资助金额:
    $ 2.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Therapeutic strategy for polyglutamine-mediated motor neuron disease via molecular chaperone-ubiquitin proteasome system
分子伴侣-泛素蛋白酶体系统治疗聚谷氨酰胺介导的运动神经元疾病的策略
  • 批准号:
    20390243
  • 财政年份:
    2008
  • 资助金额:
    $ 2.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A Fundamental Research on the Policy concerning 'The Greater East Asian Co-Prosperity Sphere'
“大东亚共荣圈”政策基础研究
  • 批准号:
    19520555
  • 财政年份:
    2007
  • 资助金额:
    $ 2.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了